168 related articles for article (PubMed ID: 15853647)
1. Progress in the development of selective inhibitors of Aurora kinases.
Mortlock A; Keen NJ; Jung FH; Heron NM; Foote KM; Wilkinson R; Green S
Curr Top Med Chem; 2005; 5(2):199-213. PubMed ID: 15853647
[TBL] [Abstract][Full Text] [Related]
2. Progress in the development of selective inhibitors of aurora kinases.
Mortlock AA; Keen NJ; Jung FH; Heron NM; Foote KM; Wilkinson RW; Green S
Curr Top Med Chem; 2005; 5(8):807-21. PubMed ID: 16101420
[TBL] [Abstract][Full Text] [Related]
3. Aurora-B kinase inhibitors for cancer chemotherapy.
Yeung SC; Gully C; Lee MH
Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of novel anti-cancer agents targeting aurora kinases.
Mahadevan D; Bearss DJ; Vankayalapati H
Curr Med Chem Anticancer Agents; 2003 Jan; 3(1):25-34. PubMed ID: 12678912
[TBL] [Abstract][Full Text] [Related]
5. Aurora-kinase inhibitors as anticancer agents.
Keen N; Taylor S
Nat Rev Cancer; 2004 Dec; 4(12):927-36. PubMed ID: 15573114
[TBL] [Abstract][Full Text] [Related]
6. Aurora kinases as anticancer drug targets.
Gautschi O; Heighway J; Mack PC; Purnell PR; Lara PN; Gandara DR
Clin Cancer Res; 2008 Mar; 14(6):1639-48. PubMed ID: 18347165
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinase inhibitors as anticancer molecules.
Katayama H; Sen S
Biochim Biophys Acta; 2010; 1799(10-12):829-39. PubMed ID: 20863917
[TBL] [Abstract][Full Text] [Related]
8. Aurora A and B kinases as targets for cancer: will they be selective for tumors?
Matthews N; Visintin C; Hartzoulakis B; Jarvis A; Selwood DL
Expert Rev Anticancer Ther; 2006 Jan; 6(1):109-20. PubMed ID: 16375648
[TBL] [Abstract][Full Text] [Related]
9. Aurora kinase family: a new target for anticancer drug.
Macarulla T; Ramos FJ; Tabernero J
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):114-22. PubMed ID: 18537754
[TBL] [Abstract][Full Text] [Related]
10. Targeting aurora kinases in cancer treatment.
Kelly KR; Ecsedy J; Mahalingam D; Nawrocki ST; Padmanabhan S; Giles FJ; Carew JS
Curr Drug Targets; 2011 Dec; 12(14):2067-78. PubMed ID: 21777198
[TBL] [Abstract][Full Text] [Related]
11. Targeting Aurora-2 kinase in cancer.
Warner SL; Bearss DJ; Han H; Von Hoff DD
Mol Cancer Ther; 2003 Jun; 2(6):589-95. PubMed ID: 12813139
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary relationships of Aurora kinases: implications for model organism studies and the development of anti-cancer drugs.
Brown JR; Koretke KK; Birkeland ML; Sanseau P; Patrick DR
BMC Evol Biol; 2004 Oct; 4():39. PubMed ID: 15476560
[TBL] [Abstract][Full Text] [Related]
13. The role of Aurora-A inhibitors in cancer therapy.
Agnese V; Bazan V; Fiorentino FP; Fanale D; Badalamenti G; Colucci G; Adamo V; Santini D; Russo A
Ann Oncol; 2007 Jun; 18 Suppl 6():vi47-52. PubMed ID: 17591831
[TBL] [Abstract][Full Text] [Related]
14. Polo and Aurora kinases: lessons derived from chemical biology.
Taylor S; Peters JM
Curr Opin Cell Biol; 2008 Feb; 20(1):77-84. PubMed ID: 18249108
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of Aurora kinase inhibitors in cancer.
Naruganahalli KS; Lakshmanan M; Dastidar SG; Ray A
Curr Opin Investig Drugs; 2006 Dec; 7(12):1044-51. PubMed ID: 17209521
[TBL] [Abstract][Full Text] [Related]
16. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.
Pérez Fidalgo JA; Roda D; Roselló S; Rodríguez-Braun E; Cervantes A
Clin Transl Oncol; 2009 Dec; 11(12):787-98. PubMed ID: 20045785
[TBL] [Abstract][Full Text] [Related]
17. Danusertib (formerly PHA-739358)--a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor.
Gontarewicz A; Brümmendorf TH
Recent Results Cancer Res; 2010; 184():199-214. PubMed ID: 20072840
[TBL] [Abstract][Full Text] [Related]
18. Aurora A kinase (AURKA) in normal and pathological cell division.
Nikonova AS; Astsaturov I; Serebriiskii IG; Dunbrack RL; Golemis EA
Cell Mol Life Sci; 2013 Feb; 70(4):661-87. PubMed ID: 22864622
[TBL] [Abstract][Full Text] [Related]
19. Update on aurora kinase inhibitors in gynecologic malignancies.
Tao X; Chon HS; Fu S; Kavanagh JJ; Hu W
Recent Pat Anticancer Drug Discov; 2008 Nov; 3(3):162-77. PubMed ID: 18991785
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinases: new targets for cancer therapy.
Carvajal RD; Tse A; Schwartz GK
Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]